Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 2/2017

01-02-2017 | Rhinology

A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea?

Authors: Murat Binar, Timur Akcam, Omer Karakoc, Rahsan Ilikci Sagkan, Ugur Musabak, Mustafa Gerek

Published in: European Archives of Oto-Rhino-Laryngology | Issue 2/2017

Login to get access

Abstract

The aim of this study was to evaluate the change in serum levels of C-reactive protein (CRP) in patients with obstructive sleep apnea (OSA) before and after expansion sphincter pharyngoplasty (ESP) and continuous positive airway pressure (CPAP) treatment. Fifty-one patients with newly diagnosed OSA were prospectively enrolled in this study. We performed ESP in twenty-three patients in the surgery group and twenty-eight patients were included in the CPAP group. Serum levels of high-sensitivity CRP (hs-CRP) were analyzed by enzyme-linked immunosorbent assays before and 3 months after treatment. The relations between CRP and the apnea hypopnea index (AHI), visual analog scale (VAS), the Epworth Sleepiness Scale (ESS), and saturation parameters were evaluated. Both surgical and CPAP treatments caused significant improvements in the clinical and laboratory parameters. However, only the patients whose postoperative AHI levels improved to final AHI of <5 (n = 6) after ESP, had significant decrease in their serum CRP levels (p = 0.028). CPAP group and the rest of the patients in the surgery group did not show statistically significant difference in CRP levels after treatment. We suggest that the successful surgical treatment for OSA—ESP in this study—, which provides OSA cure, can decrease serum levels of CRP and reduce possible cardiovascular morbidity.
Literature
1.
go back to reference Kanbay A, Ceylan E, Inonu Koseoglu H et al (2016) Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome. Clin Respir J. doi:10.1111/crj.12487 PubMed Kanbay A, Ceylan E, Inonu Koseoglu H et al (2016) Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome. Clin Respir J. doi:10.​1111/​crj.​12487 PubMed
2.
go back to reference Kokturk O, Ciftci TU, Mollarecep E et al (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46(5):801–809CrossRefPubMed Kokturk O, Ciftci TU, Mollarecep E et al (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46(5):801–809CrossRefPubMed
3.
go back to reference Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64(7):631–636PubMed Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64(7):631–636PubMed
4.
go back to reference Bassuk SS, Rifai N, Ridker PM (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29(8):439–493PubMed Bassuk SS, Rifai N, Ridker PM (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29(8):439–493PubMed
5.
go back to reference Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134CrossRefPubMed Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134CrossRefPubMed
6.
go back to reference Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464CrossRefPubMed Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464CrossRefPubMed
7.
go back to reference Nadeem R, Molnar J, Madbouly EM et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012PubMedPubMedCentral Nadeem R, Molnar J, Madbouly EM et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012PubMedPubMedCentral
8.
go back to reference Whitehead AS, Bruns GA, Markham AF et al (1983) Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science 221(4605):69–71CrossRefPubMed Whitehead AS, Bruns GA, Markham AF et al (1983) Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science 221(4605):69–71CrossRefPubMed
10.
go back to reference Blake GJ, Ridker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252(4):283–294CrossRefPubMed Blake GJ, Ridker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252(4):283–294CrossRefPubMed
11.
go back to reference Cleland SJ, Sattar N, Petrie JR et al (2000) Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci 98(5):531–535CrossRefPubMed Cleland SJ, Sattar N, Petrie JR et al (2000) Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci 98(5):531–535CrossRefPubMed
12.
go back to reference Fichtlscherer S, Rosenberger G, Walter DH et al (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102(9):1000–1006CrossRefPubMed Fichtlscherer S, Rosenberger G, Walter DH et al (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102(9):1000–1006CrossRefPubMed
13.
go back to reference Ridker PM, Cook N (2004) Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109(16):1955–1959CrossRefPubMed Ridker PM, Cook N (2004) Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109(16):1955–1959CrossRefPubMed
14.
go back to reference Albert CM, Ma J, Rifai N et al (2002) Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105(22):2595–2599CrossRefPubMed Albert CM, Ma J, Rifai N et al (2002) Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105(22):2595–2599CrossRefPubMed
15.
go back to reference Wu H, Yuan X, Wang L et al (2016). The relationship between obstructive sleep apnea hypopnea syndrome and inflammatory markers and quality of life in subjects with acute coronary syndrome. Respir Care (Epub ahead of print) Wu H, Yuan X, Wang L et al (2016). The relationship between obstructive sleep apnea hypopnea syndrome and inflammatory markers and quality of life in subjects with acute coronary syndrome. Respir Care (Epub ahead of print)
16.
go back to reference Kataoka T, Enomoto F, Kim R et al (2004) The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med 204(4):267–272CrossRefPubMed Kataoka T, Enomoto F, Kim R et al (2004) The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med 204(4):267–272CrossRefPubMed
17.
go back to reference Constantinidis J, Ereliadis S, Angouridakis N et al (2008) Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 265(10):1275–1279CrossRefPubMed Constantinidis J, Ereliadis S, Angouridakis N et al (2008) Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 265(10):1275–1279CrossRefPubMed
18.
go back to reference Pang KP, Woodson BT (2007) Expansion sphincter pharyngoplasty: a new technique for the treatment of obstructive sleep apnea. Otolaryngol Head Neck Surg 137(1):110–114CrossRefPubMed Pang KP, Woodson BT (2007) Expansion sphincter pharyngoplasty: a new technique for the treatment of obstructive sleep apnea. Otolaryngol Head Neck Surg 137(1):110–114CrossRefPubMed
19.
go back to reference Sorrenti G, Piccin O (2013) Functional expansion pharyngoplasty in the treatment of obstructive sleep apnea. Laryngoscope 123(11):2905–2908CrossRefPubMed Sorrenti G, Piccin O (2013) Functional expansion pharyngoplasty in the treatment of obstructive sleep apnea. Laryngoscope 123(11):2905–2908CrossRefPubMed
20.
go back to reference Vicini C, Montevecchi F, Pang K et al (2014) Combined transoral robotic tongue base surgery and palate surgery in obstructive sleep apnea-hypopnea syndrome: expansion sphincter pharyngoplasty versus uvulopalatopharyngoplasty. Head Neck 36(1):77–83CrossRefPubMed Vicini C, Montevecchi F, Pang K et al (2014) Combined transoral robotic tongue base surgery and palate surgery in obstructive sleep apnea-hypopnea syndrome: expansion sphincter pharyngoplasty versus uvulopalatopharyngoplasty. Head Neck 36(1):77–83CrossRefPubMed
21.
go back to reference Ulualp SO (2014) Modified expansion sphincter pharyngoplasty for treatment of children with obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg 140(9):817–822CrossRefPubMed Ulualp SO (2014) Modified expansion sphincter pharyngoplasty for treatment of children with obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg 140(9):817–822CrossRefPubMed
22.
go back to reference Carrasco-Llatas M, Marcano-Acuna M, Zerpa-Zerpa V et al (2015) Surgical results of different palate techniques to treat oropharyngeal collapse. Eur Arch Otorhinolaryngol 272(9):2535–2540CrossRefPubMed Carrasco-Llatas M, Marcano-Acuna M, Zerpa-Zerpa V et al (2015) Surgical results of different palate techniques to treat oropharyngeal collapse. Eur Arch Otorhinolaryngol 272(9):2535–2540CrossRefPubMed
23.
go back to reference Pang KP, Pang EB, Win MT et al (2015) Expansion sphincter pharyngoplasty for the treatment of OSA: a systemic review and meta-analysis. Eur Arch Otorhinolaryngol (Epub ahead of print) Pang KP, Pang EB, Win MT et al (2015) Expansion sphincter pharyngoplasty for the treatment of OSA: a systemic review and meta-analysis. Eur Arch Otorhinolaryngol (Epub ahead of print)
24.
go back to reference Woodson BT, Karakoc O (2011) The expansion sphincter pharyngoplasty for obstructive sleep apnea. In: Yaremchuk KL, Wardrop PA (eds) Sleep medicine. Plural Publishing, San Diego, pp 301–309 Woodson BT, Karakoc O (2011) The expansion sphincter pharyngoplasty for obstructive sleep apnea. In: Yaremchuk KL, Wardrop PA (eds) Sleep medicine. Plural Publishing, San Diego, pp 301–309
25.
go back to reference Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619PubMedPubMedCentral Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619PubMedPubMedCentral
26.
go back to reference Kezirian EJ, Weaver EM, Criswell MA et al (2011) Reporting results of obstructive sleep apnea syndrome surgery trials. Otolaryngol Head Neck Surg 144(4):496–499CrossRefPubMed Kezirian EJ, Weaver EM, Criswell MA et al (2011) Reporting results of obstructive sleep apnea syndrome surgery trials. Otolaryngol Head Neck Surg 144(4):496–499CrossRefPubMed
27.
go back to reference Htoo AK, Greenberg H, Tongia S et al (2006) Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10(1):43–50CrossRefPubMed Htoo AK, Greenberg H, Tongia S et al (2006) Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10(1):43–50CrossRefPubMed
28.
go back to reference Duchna HW, Orth M, Schultze-Werninghaus G et al (2005) Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 9(3):97–103CrossRefPubMed Duchna HW, Orth M, Schultze-Werninghaus G et al (2005) Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 9(3):97–103CrossRefPubMed
29.
go back to reference Ridker PM, Danielson E, Fonseca FA et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373(9670):1175–1182CrossRefPubMed Ridker PM, Danielson E, Fonseca FA et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373(9670):1175–1182CrossRefPubMed
30.
go back to reference Taheri S, Austin D, Lin L et al (2007) Correlates of serum C-reactive protein (CRP)—no association with sleep duration or sleep disordered breathing. Sleep 30(8):991–996PubMedPubMedCentral Taheri S, Austin D, Lin L et al (2007) Correlates of serum C-reactive protein (CRP)—no association with sleep duration or sleep disordered breathing. Sleep 30(8):991–996PubMedPubMedCentral
31.
go back to reference Ryan S, Nolan GM, Hannigan E et al (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62(6):509–514CrossRefPubMedPubMedCentral Ryan S, Nolan GM, Hannigan E et al (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62(6):509–514CrossRefPubMedPubMedCentral
32.
go back to reference Ishida K, Kato M, Kato Y et al (2009) Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 136(1):125–129CrossRefPubMedPubMedCentral Ishida K, Kato M, Kato Y et al (2009) Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 136(1):125–129CrossRefPubMedPubMedCentral
33.
go back to reference Wu SQ, Liao QC, Xu XX et al (2016) Effect of CPAP therapy on C-reactive protein and cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath (Epub ahead of print) Wu SQ, Liao QC, Xu XX et al (2016) Effect of CPAP therapy on C-reactive protein and cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome. Sleep Breath (Epub ahead of print)
34.
go back to reference Punjabi NM, Beamer BA (2007) C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30(1):29–34PubMed Punjabi NM, Beamer BA (2007) C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30(1):29–34PubMed
35.
go back to reference Barcelo A, Barbe F, Llompart E et al (2004) Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117(2):118–121CrossRefPubMed Barcelo A, Barbe F, Llompart E et al (2004) Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117(2):118–121CrossRefPubMed
36.
go back to reference Sharma SK, Mishra HK, Sharma H et al (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9(2):149–156CrossRefPubMed Sharma SK, Mishra HK, Sharma H et al (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9(2):149–156CrossRefPubMed
Metadata
Title
A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea?
Authors
Murat Binar
Timur Akcam
Omer Karakoc
Rahsan Ilikci Sagkan
Ugur Musabak
Mustafa Gerek
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 2/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-4290-0

Other articles of this Issue 2/2017

European Archives of Oto-Rhino-Laryngology 2/2017 Go to the issue